4.8 Article

Increased Serum Levels of sCD14 and sCD163 Indicate a Preponderant Role for Monocytes in COVID-19 Immunopathology

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Infectious Diseases

Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality

Chi Zhang et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)

Letter Medicine, General & Internal

COVID-19: consider cytokine storm syndromes and immunosuppression

Puja Mehta et al.

LANCET (2020)

Review Infectious Diseases

Role of Monocytes/Macrophages in Covid-19 Pathogenesis: Implications for Therapy

Jose Gomez-Rial et al.

INFECTION AND DRUG RESISTANCE (2020)

Review Infectious Diseases

The pathogenesis and treatment of the 'Cytokine Storm' in COVID-19

Qing Ye et al.

JOURNAL OF INFECTION (2020)

Article Immunology

How Viruses Contribute to the Pathogenesis of Hemophagocytic Lymphohistiocytosis

Ellen Brisse et al.

FRONTIERS IN IMMUNOLOGY (2017)

Article Pharmacology & Pharmacy

Modulation of human monocyte/macrophage activity by tocilizumab, abatacept and etanercept: An in vitro study

Joyce Afrakoma Obeng et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2016)

Article Immunology

Soluble CD14 is a nonspecific marker of monocyte activation

Carey L. Shive et al.

Article Immunology

Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection

Netanya G. Sandler et al.

JOURNAL OF INFECTIOUS DISEASES (2011)